Kirsten Flowers's most recent trade in PMV Pharmaceuticals Inc was a trade of 33,500 Stock Option (right to buy) done . Disclosure was reported to the exchange on June 5, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| PMV Pharmaceuticals Inc | Kirsten Flowers | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jun 2025 | 33,500 | 33,500 | - | - | Stock Option (right to buy) | |
| PMV Pharmaceuticals Inc | Kirsten Flowers | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jun 2024 | 67,500 | 67,500 | - | - | Stock Option (right to buy) | |
| PMV Pharmaceuticals Inc | Kirsten Flowers | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Jun 2023 | 21,500 | 21,500 | - | - | Stock Option (right to buy) | |
| Comera Life Sciences Holdi... | Kirsten Flowers | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 May 2023 | 39,491 | 39,491 | - | - | Stock Option (Right to Purchase) | |
| Comera Life Sciences Holdi... | Kirsten Flowers | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Feb 2023 | 7,100 | 7,100 | - | - | Stock Option (Right to Purchase) | |
| Kura Oncology Inc | Kirsten Flowers | CCO & Chief Strategy Officer | Sale of securities on an exchange or to another person at price $ 13.89 per share. | 27 Jan 2023 | 1,906 | 20,605 (0%) | 0% | 13.9 | 26,474 | Common Stock |
| Comera Life Sciences Holdi... | Kirsten Flowers | Director | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 04 Jan 2023 | 13,513 | 13,513 | - | - | Warrant (Right to Buy) | |
| Comera Life Sciences Holdi... | Kirsten Flowers | Director | Purchase of securities on an exchange or from another person at price $ 1.23 per share. | 04 Jan 2023 | 13,513 | 22,199 | - | 1.2 | 16,621 | Common Stock |
| Comera Life Sciences Holdi... | Kirsten Flowers | Director | 31 Dec 2022 | 44,981 | 44,981 | - | - | Stock Option (Right to Buy) | ||
| PMV Pharmaceuticals Inc | Kirsten Flowers | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jun 2022 | 19,500 | 19,500 | - | - | Stock Option (right to buy) | |
| Kura Oncology Inc | Kirsten Flowers | Chief Commercial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Jan 2022 | 171,000 | 171,000 | - | - | Option to purchase common stock | |
| Kura Oncology Inc | Kirsten Flowers | Chief Commercial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Jan 2022 | 21,900 | 22,511 (0%) | 0% | 0 | Common Stock | |
| PMV Pharmaceuticals Inc | Kirsten Flowers | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Jan 2022 | 32,677 | 32,677 | - | - | Stock Option (right to buy) | |
| Kura Oncology Inc | Kirsten Flowers | Chief Commercial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Jan 2021 | 125,000 | 125,000 | - | - | Option to purchase common stock |